Browsing Tag
Incheon
4 posts
Samsung Biologics is not just buying PolyPeptide. It is buying into the GLP-1 supply chain
Samsung Biologics plans to acquire PolyPeptide for CHF 1.46 billion. Read how the deal targets peptide CDMO capacity and GLP-1 manufacturing demand.
Samsung Bioepis-NIPRO alliance boosts biosimilar pipeline in Japan’s $1.4B market
Samsung Bioepis (KRX: 207940) and NIPRO’s biosimilar partnership expands Japan market access amid rising healthcare costs and global biologics competition.
Sartorius to invest €270m to expand South Korea operations
Sartorius, a German pharma and lab equipment supplier, said that it is investing nearly €270 million through 2024…
Samsung Biologics to manufacture Moderna’s mRNA-1273 COVID-19 vaccine
Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake…